Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
119
NCT02391194
Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2015
Completion: Jan 31, 2017
NCT03113825
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Phase: Phase 2
Start: Jul 5, 2017
Completion: Nov 18, 2020